“Oral coadministration of oltipraz , an antischistosomal compound, with cysteine to green monkeys (Cercopithecus aethiops) led to a marked increase in both the extent and rate of oltipraz bioavailability.”
“The marked increase in oltipraz bioavailability produced by coadministration of cysteine , irrespective of the exact mechanisms involved, may have significant clinical implications with regard to the treatment of schistosomiasis.”
“When 6 healthy adult animals were given oltipraz together with cysteine in a crossover study, peak serum concentrations, areas under the curve and absorption rate constants of oltipraz were on average 7 times greater than when the drug was administered alone.”